VEGFA and breast cancer: In breast cancer [33], the miR-205/YAP1 in CAFs displays a concordant effect in VEGF-independent angiogenesis, by targeting IL-11 and IL-15 to activate the STAT3 signaling pathway in endothelial cells, which may provide a possibility for resistance to anti-VEGF therapy.